| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 01/21/2010 | US20100016228 Truncated bard1 protein, and its diagnostic and therapeutic uses |
| 01/21/2010 | US20100016216 Adiponectin and uses thereof |
| 01/21/2010 | US20100015725 Luminescent 1-hydroxy-2-pyridinone chelates of lanthanides |
| 01/21/2010 | US20100015724 Lysine acetylation sites |
| 01/21/2010 | US20100015723 Antagonists of Interleukin-15 |
| 01/21/2010 | US20100015703 Antibody to mammalian cytokine-like polypeptide-10 |
| 01/21/2010 | US20100015665 Antibodies and diagnostics |
| 01/21/2010 | US20100015644 Potency assays for antibody drug substance binding to an fc receptor |
| 01/21/2010 | US20100015641 Diagnostic agent for tumor |
| 01/21/2010 | US20100015637 Pigf-1 assay and kits and components thereof |
| 01/21/2010 | US20100015632 Method for examining colorectal cancer and colorectal adenoma |
| 01/21/2010 | US20100015600 Method for diagnosing and treating crohn's disease |
| 01/21/2010 | US20100015597 Production of biological carriers for induction of immune response and inhibition of viral replication |
| 01/21/2010 | US20100015596 Rs virus detecting kit using anti-rs virus monoclonal antibody, immuno-chromatographic test device, and new anti-rs virus monoclonal antibody |
| 01/21/2010 | US20100015593 Method for producing a composition for promoting survival of transplanted hematopoietic stem cell |
| 01/21/2010 | US20100015175 Vaccine |
| 01/21/2010 | US20100015170 Flagellin mutant vaccine |
| 01/21/2010 | US20100015169 Tumor Antigens |
| 01/21/2010 | US20100015166 Therapeutic antibodies |
| 01/21/2010 | US20100015163 Dendritic cell potentiation |
| 01/21/2010 | US20100015155 Pegylated abeta fab |
| 01/21/2010 | US20100015154 Immunogenic memapsin 2 b-secretase peptides and methods of use |
| 01/21/2010 | US20100015153 Novel Triggering Receptor Involved in Natural Cytotoxicity Mediated by Human Natural Killer Cells and Antibodies That Identify the Same |
| 01/21/2010 | US20100015151 Polypeptides from neisseria meningitidis |
| 01/21/2010 | US20100015150 Tdf-related compounds and analogs thereof |
| 01/21/2010 | US20100015145 Use of a compound for reducing the biological effectiveness of IL-6 |
| 01/21/2010 | US20100015138 Crystal structure of Staphylococcus aureus clumping factor a in complex with fibrinogen derived peptide and uses thereof |
| 01/21/2010 | US20100015135 Anti-ephb4 antibodies and methods using same |
| 01/21/2010 | US20100015134 Therapy With CD4 Binding Peptides and Radiation |
| 01/21/2010 | US20100015133 Methods for Producing Polypeptides by Regulating Polypeptide Association |
| 01/21/2010 | US20100015131 Composition Comprising Antibodies to LINGO or Fragments Thereof |
| 01/21/2010 | US20100015124 Modulation of epidermal growth factor heterodimer activity |
| 01/21/2010 | US20100015113 Gp100-specific t cell receptors and related materials and methods of use |
| 01/21/2010 | US20100015101 Novel tumor antigen peptides |
| 01/21/2010 | US20100015089 Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation |
| 01/21/2010 | US20100015056 Uranium-chelating peptides and uses thereof |
| 01/21/2010 | US20100015048 Internalizing Anti-CD74 Antibodies and Methods of Use |
| 01/21/2010 | US20100015047 Lung-Expressed Polypeptides |
| 01/21/2010 | US20100015045 Cancerous Disease Modifying Antibodies |
| 01/21/2010 | DE102008033381A1 Modulation der Immunantwort durch den Rezeptor NKp65 und seine Liganden Modulation of the immune response by the receptor NKp65 and its ligands |
| 01/21/2010 | DE10004815B4 Menschliche intestinale Natriumphosphat-Kotransporter Human intestinal sodium phosphate cotransporter |
| 01/21/2010 | CA2731296A1 New mutated netrin 4 proteins, fragments thereof and their uses as drugs |
| 01/21/2010 | CA2731220A1 Antagonistic cd28 monovalent domain antibodies |
| 01/21/2010 | CA2731216A1 Compositions for the detection and treatment of colorectal cancer |
| 01/21/2010 | CA2731129A1 Cancerous disease modifying antibodies |
| 01/21/2010 | CA2730776A1 Human cytomegalovirus neutralizing antibodies and use thereof |
| 01/21/2010 | CA2730620A1 Human cytomegalovirus neutralising antibodies and use thereof |
| 01/21/2010 | CA2730063A1 Compositions and methods of use for therapeutic antibodies |
| 01/21/2010 | CA2729899A1 Methods for systematic control of protein stability |
| 01/21/2010 | CA2729185A1 Functionalized polypeptides |
| 01/20/2010 | EP2145961A2 Porcine adenovirus type 3 genome |
| 01/20/2010 | EP2145954A1 Anti-A33 antibody |
| 01/20/2010 | EP2145902A2 Tyrosine phosphorylation sites and antibodies specific for them |
| 01/20/2010 | EP2145901A1 Recombinant anti-MUC1 antibodies |
| 01/20/2010 | EP2145900A1 Orai1 (CRACM1) is the platelet SOC channel and essential for pathological thrombus formation |
| 01/20/2010 | EP2145899A1 RS virus detecting kit using anti-RS virus monoclonal antibody, immuno-chromatographic test device, and new anti-RS virus monoclonal antibody |
| 01/20/2010 | EP2145896A2 Recovery of a heat shock protein |
| 01/20/2010 | EP2145003A2 Polynucleotides and polypeptides involved in gestational malaria, and biological applications |
| 01/20/2010 | EP2144997A1 Cancerous disease modifying antibodies |
| 01/20/2010 | EP2144996A1 Carbon and nitrogen-regulating gene and protein and modulation thereof |
| 01/20/2010 | EP2144934A1 Antibodies against il-25 |
| 01/20/2010 | EP2144933A2 Anti-amyloid antibodies and their use in diagnosis and therapy of amyloid diseases |
| 01/20/2010 | EP2144932A1 Novel antibody molecules and nucleic acids binding to fungal stress protein hsp90 |
| 01/20/2010 | EP2144931A2 Monoclonal antibodies against dengue and other viruses with deletion in fc region |
| 01/20/2010 | EP2144930A1 Single chain fc, methods of making and methods of treatment |
| 01/20/2010 | EP1860184B1 Novel polypeptide, polynucleotide encoding the polypeptide and use the polypeptide and polynucleotide |
| 01/20/2010 | EP1599227B1 Methods of immunomodulation in animals |
| 01/20/2010 | EP1571211B1 Antibodies against lesional tissues |
| 01/20/2010 | EP1487493B1 Conjugates of cytotoxic agents and biologically active peptides |
| 01/20/2010 | EP1379272B1 Monoclonal antibodies directed against molecular mimetics of meningococcal b epitopes |
| 01/20/2010 | EP1188830B1 Novel hemopoietin receptor protein ,nr10 |
| 01/20/2010 | CN101631802A Anti-human Dlk-1 antibody showing anti-tumor activity in vivo |
| 01/20/2010 | CN101628940A Monoclonal antibody and application thereof |
| 01/20/2010 | CN101628939A Therapeutic human anti-IL-1R1 monoclonal antibody |
| 01/20/2010 | CN101628933A HIV peptides from tat, rev and wef conserved and their application as e.g. vaccine components |
| 01/20/2010 | CN101628111A TACI-immunoglobulin fusion proteins |
| 01/20/2010 | CN100582782C Plasma urotensin in human heart failure |
| 01/20/2010 | CN100582226C Genes encoding proteolytic enzymes from aspargilli |
| 01/20/2010 | CN100581585C Novel remedies for cancer |
| 01/19/2010 | US7649085 Saquinavir conjugates and antibodies useful in immunoassay |
| 01/19/2010 | US7649083 An immunoglobulin heavy chain variable region, an immunoglobulin light chain variable region, together define a single binding site for binding human HGF; neutralizing the activity of HGF |
| 01/19/2010 | US7649082 Glial-derived neurotrophic factor (GDNF)/neurturin family of growth factors; Neurodegenerative disorders; used in preventing the atrophy, degeneration or death of certain cells, in particular neurons |
| 01/19/2010 | US7649081 Diagnostic method for diseases by screening for hepcidin in human or animal tissues, blood or body fluids and therapeutic uses therefor |
| 01/19/2010 | US7648962 which retain activity for stimulating cyclic guanosine monophosphate production and binding to natriuretic peptide receptor type A; improved bioavailability and half-life in circulation; for treatment of congestive heart failure |
| 01/19/2010 | US7648703 Combination of anti-EP-CAM antibody with a chemotherapeutic agent |
| 01/19/2010 | US7648701 Peptide composition as immunogen for the treatment of allergy |
| 01/19/2010 | CA2123492C Lymphoid antigen cd30 |
| 01/14/2010 | WO2010006296A2 New avian bornavirus |
| 01/14/2010 | WO2010006286A2 Constructs and libraries comprising antibody surrogate kappa light chain sequences |
| 01/14/2010 | WO2010006214A1 Fgf-21 neutralizing antibodies and their uses |
| 01/14/2010 | WO2010006136A2 Adenovirus targeting |
| 01/14/2010 | WO2010005863A1 Surface display of whole antibodies in eukaryotes |
| 01/14/2010 | WO2010005570A2 Compositions comprising antibodies to lingo or fragments thereof |
| 01/14/2010 | WO2010005389A1 Oxidized ldl specific antibody-fusion and conjugated proteins |
| 01/14/2010 | WO2010005364A1 Separation medium for chromatography of various biomolecules |
| 01/14/2010 | WO2010005068A1 Pharmaceutical composition for treatment and prevention of cancer |
| 01/14/2010 | WO2010005067A1 Reagent for detecting type of allele based on polymorphism of siglec14 gene |
| 01/14/2010 | WO2010004434A2 Method of promoting neurogenesis |
| 01/14/2010 | WO2010004432A1 Variable domains of camelid heavy-chain antibodies directed against glial fibrillary acidic proteins |
| 01/14/2010 | WO2010004276A2 Antibody |